Top

Published in:

01-07-2015 | Colorectal Cancer

Robotic Rectal Cancer Resection: A Retrospective Multicenter Analysis

Authors: Minia Hellan, MD, FACS, James Ouellette, DO, Jorge A. Lagares-Garcia, MD, Stephen M. Rauh, MD, Harold L. Kennedy, MD, John D. Nicholson, MD, David Nesbitt, MD, Craig S. Johnson, MD, Alessio Pigazzi, MD, PhD

Published in: Annals of Surgical Oncology | Issue 7/2015

Abstract

Background

Conventional laparoscopy has been applied to colorectal resections for more than 2 decades. However, laparoscopic rectal resection is technically demanding, especially when performing a tumor-specific mesorectal excision in a difficult pelvis. Robotic surgery is uniquely designed to overcome most of these technical limitations. The aim of this study was to confirm the feasibility of robotic rectal cancer surgery in a large multicenter study.

Methods

Retrospective data of 425 patients who underwent robotic tumor-specific mesorectal excision for rectal lesions at seven institutions were collected. Outcome data were analyzed for the overall cohort and were stratified according to obese versus non-obese and low versus ultra-low resection patients.

Results

Mean age was 60.9 years, and 57.9 % of patients were male. Overall, 51.3 % of patients underwent neoadjuvant therapy, while operative time was 240 min, mean blood loss 119 ml, and intraoperative complication rate 4.5 %. Mean number of lymph nodes was 17.4, with a positive circumferential margin rate of 0.9 %. Conversion rate to open was 5.9 %, anastomotic leak rate was 8.7 %, with a mean length of stay of 5.7 days. Operative times were significantly longer and re-admission rate higher for the obese population, with all other parameters comparable. Ultra-low resections also had longer operative times.

Conclusion

Robotic-assisted minimally invasive surgery for the treatment of rectal cancer is safe and can be performed according to current oncologic principles. BMI seems to play a minor role in influencing outcomes. Thus, robotics might be an excellent treatment option for the challenging patient undergoing resection for rectal cancer.

Huang MJ, Liang JL, Wang H, Kang L, Deng YH, Wang JP. Laparoscopic-assisted versus open surgery for rectal cancer: a meta-analysis of randomized controlled trials on oncologic adequacy of resection and long-term oncologic outcomes. Int J Colorectal Dis. 2011;26:415–421.PubMedCrossRef

Trastulli S, Cirocchi R, Listorti C, et al. Laparoscopic vs open resection for rectal cancer: a meta-analysis of randomized clinical trials. Colorectal Dis. 2012;14:e277–e296.PubMedCrossRef

Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365:1718–1726.PubMedCrossRef

Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010;97:1638–1645.PubMedCrossRef

Arezzo A, Passera R, Salvai A, Arolfo S, Allaix ME, Schwarzer G, et al. Laparoscopy for rectal cancer is oncologically adequate: a systematic review and meta-analysis of the literature. Surg Endosc. 2014;doi:10.1007/s00464-014-3686-4.

Arezzo A, Passera R, Scozzari G, Verra M, Morino M. Laparoscopy for rectal cancer reduces short-term mortality and morbidity: results of a systematic review and meta-analysis. Surg Endosc. 2013;27:1485–1502.PubMedCrossRef

Mathis KL, Nelson H. Controversies in laparoscopy for colon and rectal cancer. Surg Oncol Clin N Am. 2014;23:35–47.PubMedCrossRef

Row D, Weiser MR. An update on laparoscopic resection for rectal cancer. Cancer Control. 2010;17:16–24.PubMed

Pigazzi A, Luca F, Patriti A, et al. Multicentric study on robotic tumor-specific mesorectal excision for the treatment of rectal cancer. Ann Surg Oncol. 2010;17:1614–1620.PubMedCrossRef

10.

van der Pas MH, Haglind E, Cuesta MA, Fuerst A, Lacy AM, Hop WC, et al. Colorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013; 14:210–218.PubMedCrossRef

11.

Agha A, Benseler V, Hornung M, et al. Long-term oncologic outcome after laparoscopic surgery for rectal cancer. Surg Endosc. 2014;28:1119–1125.PubMedCrossRef

12.

Dulucq JL, Wintringer P, Stabilini C, Mahajna A. Laparoscopic rectal resection with anal sphincter preservation for rectal cancer: long-term outcome. Surg Endosc. 2005;19:1468–1474.PubMedCrossRef

13.

Ng KH, Ng DC, Cheung HY, Wong JC, Yau KK, Chung CC, et al. Laparoscopic resection for rectal cancers: lessons learned from 579 cases. Ann Surg. 2009;249:82–86.PubMedCrossRef

14.

Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol. 2007;25:3061–3068.PubMedCrossRef

15.

Scheidbach H, Rose J, Huegel O, Yildirim C, Kockerling F. Results of laparoscopic treatment of rectal cancer: analysis of 520 patients. Tech Coloproctol. 2004;8 Suppl 1:s22–s24.PubMedCrossRef

16.

Makino T, Shukla PJ, Rubino F, Milsom JW. The impact of obesity on perioperative outcomes after laparoscopic colorectal resection. Ann Surg. 2012;255:228–236.PubMedCrossRef

17.

Zhou Y, Wu L, Li X, Wu X, Li B. Outcome of laparoscopic colorectal surgery in obese and nonobese patients: a meta-analysis. Surg Endosc. 2012;26:783–789.PubMedCrossRef

18.

Wexner SD, Bergamaschi R, Lacy A, Udo J, Brölmann H, Kennedy RH, et al. The current status of robotic pelvic surgery: results of a multinational interdisciplinary consensus conference. Surg Endosc. 2009;23(2):438–443.PubMedCrossRef

19.

van der Schatte Olivier RH, Van’t Hullenaar CD, Ruurda JP, Broeders IA. Ergonomics, user comfort, and performance in standard and robot-assisted laparoscopic surgery. Surg Endosc. 2009;23:1365–1371.PubMedCentralPubMedCrossRef

20.

Hagen ME, Inan I, Pugin F, Morel P. The da Vinci surgical system in digestive surgery [in French]. Rev Med Suisse. 2007;3:1622–1666.PubMed

21.

Heemskerk J, Zandbergen HR, Keet SW, et al. Relax, it’s just laparoscopy! A prospective randomized trial on heart rate variability of the surgeon in robot-assisted versus conventional laparoscopic cholecystectomy. Dig Surg. 2014;31:225–232.PubMedCrossRef

22.

deSouza AL, Prasad LM, Marecik SJ, Blumetti J, Park JJ, Zimmern A, et al. Total mesorectal excision for rectal cancer: the potential advantage of robotic assistance. Dis Colon Rectum. 2010;53:1611–1617.PubMedCrossRef

23.

Baek JH, Pastor C, Pigazzi A. Robotic and laparoscopic total mesorectal excision for rectal cancer: a case-matched study. Surg Endosc. 2011;25:521–525.PubMedCrossRef

24.

Park JS, Choi GS, Lim KH, Jang YS, Jun SH. S052: a comparison of robot-assisted, laparoscopic, and open surgery in the treatment of rectal cancer. Surg Endosc. 2011;25:240–248.PubMedCrossRef

25.

Kim JY, Kim NK, Lee KY, Hur H, Min BS, Kim JH. A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery. Ann Surg Oncol. 2012;19:2485–2493.PubMedCrossRef

26.

Baik SH, Ko YT, Kang CM, et al. Robotic tumor-specific mesorectal excision of rectal cancer: short-term outcome of a pilot randomized trial. Surg Endosc. 2008;22:1601–1608.PubMedCrossRef

27.

deSouza AL, Prasad LM, Ricci J, et al. A comparison of open and robotic total mesorectal excision for rectal adenocarcinoma. Dis Colon Rectum. 2011;54:275–282.PubMedCrossRef

28.

Biffi R, Luca F, Pozzi S, et al. Operative blood loss and use of blood products after full robotic and conventional low anterior resection with total mesorectal excision for treatment of rectal cancer. J Robot Surg. 2011;5:101–107.PubMedCentralPubMedCrossRef

29.

Bianchi PP, Ceriani C, Locatelli A, et al. Robotic versus laparoscopic total mesorectal excision for rectal cancer: a comparative analysis of oncological safety and short-term outcomes. Surg Endosc. 2010;24:2888–2894.PubMedCrossRef

30.

World Health Organization. Obesity and overweight fact sheet no. 311. http://www.who.int/mediacentre/factsheets/fs311/en/index.html (2014). Accessed 18 May 2014.

31.

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213.PubMedCentralPubMedCrossRef

32.

American Joint Committee on Cancer. Colon and rectum cancer staging. 7th edition (2010). Available from: https://cancerstaging.org. Accessed 18 May 2014.

33.

Surgical Care Improvement Project (SCIP) guidelines. http://surgery.uc.edu/content/Education/residentresources/SCIP%20one%20page%20guidelines%20draft%204%204-24-2012.pdf. Accessed 18 May 2014.

34.

Trastulli S, Farinella E, Cirocchi R, et al. Robotic resection compared with laparoscopic rectal resection for cancer: systematic review and meta-analysis of short-term outcome. Colorectal Dis. 2012;14(4):e134–e156.PubMedCrossRef

35.

Quirke P, Durdey P, Dixon MF, Williams NF. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumor spread and surgical excision. Lancet. 1986;328:996–999.CrossRef

36.

Heald RJ, Moran BJ, Ryall RD, Sexton R, MaxFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision. Arch Surg. 1998;133:894–899.PubMedCrossRef

37.

Green BL, Marshall HC, Collinson F, Quirke P, Guillou P, Jayne DG, et al. Long-term follow-up of the Medical Research Council CLASSICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg. 2013;100:75–82.PubMedCrossRef

38.

Ghezzi TL, Luca F, Valvo M, Corleta OC, Zuccaro M, Cenciarelli S, et al. Robotic versus open total mesorectal excision for rectal cancer: comparative study of short and long-term outcomes. Eur J Surg Oncol. 2014;40:1072–1079.PubMedCrossRef

39.

Hara M, Sng K, Yoo BE, Shin JW, Lee DW, Kim SH. Robotic-assisted surgery for rectal adenocarcinoma: short-term and midterm outcomes from 200 consecutive cases at a single institution. Dis Colon Rectum. 2014;57:570–577.PubMedCrossRef

40.

Collinson FJ, Jayne DG, Pigazzi A, et al. An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer. Int J Colorectal Dis. 2012;27:233–241.PubMedCrossRef

41.

Halabi WJ, Kang CY, Jafari MD, et al. Robotic-assisted colorectal surgery in the United States: a nationwide analysis of trends and outcomes. World J Surg. 2013;37:2782–2790.PubMedCrossRef

42.

Park IJ, You YN, Schlette E, Nguyen S, Skibber JM, Rodriguez-Bigas MA, et al. Reverse-hybrid robotic mesorectal excision for rectal cancer. Dis Colon Rectum. 2012;55:228–233.PubMedCentralPubMedCrossRef

43.

Kang J, Yoon KJ, Min BS, Hur H, Baik SH, Kim NK, et al. The impact of robotic surgery for mid and low rectal cancer: a case-matched analysis of a 3-arm comparison–open, laparoscopic, and robotic surgery. Ann Surg. 2013;257:95–101.PubMedCrossRef

44.

Ballian N, Yamane B, Leverson G, Harms B, Heise C, Foley E, et al. Body mass index does not affect postoperative morbidity and oncologic outcomes of total mesorectal excision for rectal adenocarcinoma. Ann Surg Oncol. 2010;17:1606–1613.PubMedCrossRef

45.

Krane MK, Allaix ME, Zoccali M, et al. Does morbid obesity change outcomes after laparoscopic surgery for inflammatory bowel disease? Review of 626 consecutive cases. J Am Coll Surg. 2013;216:986–996.PubMedCrossRef

46.

Mustain WC, Davenport DL, Hourigan JS, Vargas HD. Obesity and laparoscopic colectomy: outcomes from the ACS-NSQIP database. Dis Colon Rectum. 2012;55:429–435.PubMedCrossRef

47.

Akiyoshi T, Ueno M, Fukunaga Y, et al. Effect of body mass index on short-term outcomes of patients undergoing laparoscopic resection for colorectal cancer: a single institution experience in Japan. Surg Laparosc Endosc Percutan Tech. 2011;21:409–414.PubMedCrossRef

48.

Bege T, Lelong B, Francon D, Turrini O, Guiramand J, Delpero JR. Impact of obesity on short term results of laparoscopic rectal cancer resection. Surg Endosc. 2009;23:1460–1464.PubMedCrossRef

49.

Jafari M, Halabi W, Jafari F, et al. Morbidity of diverting ileostomy for rectal cancer: analysis of the American College of Surgeons National Surgical Quality Improvment Program. Am Surg. 2013;79:1034–1039.PubMed

Title: Robotic Rectal Cancer Resection: A Retrospective Multicenter Analysis
Authors: Minia Hellan, MD, FACS
James Ouellette, DO
Jorge A. Lagares-Garcia, MD
Stephen M. Rauh, MD
Harold L. Kennedy, MD
John D. Nicholson, MD
David Nesbitt, MD
Craig S. Johnson, MD
Alessio Pigazzi, MD, PhD
Publication date: 01-07-2015
Publisher: Springer US
Published in: Annals of Surgical Oncology / Issue 7/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-014-4278-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Robotic Rectal Cancer Resection: A Retrospective Multicenter Analysis

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2015

Older Age is Associated with a Higher Incidence of Melanoma Death but a Lower Incidence of Sentinel Lymph Node Metastasis in the SEER Databases (2003–2011)

Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery

Surgical Referral for Colorectal Liver Metastases: A Population-Based Survey

Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma

Quality of Life in Platinum-Sensitive Recurrent Ovarian Cancer: Chemotherapy Versus Surgery Plus Chemotherapy

Effects of Preoperative Chemoradiotherapy on the Likelihood of Sphincter Preservation Surgery in Locally Advanced Distal Rectal Cancer: A Longitudinal Study Based on Pelvic Magnetic Resonance Imaging